Median Diagnostics Statistics
Total Valuation
Median Diagnostics has a market cap or net worth of KRW 24.43 billion.
Market Cap | 24.43B |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Median Diagnostics has 1.75 million shares outstanding.
Shares Outstanding | 1.75M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 5.88% |
Owned by Institutions (%) | n/a |
Float | 390,970 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.04 |
PB Ratio | 2.60 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.31, with a Debt / Equity ratio of 70.39.
Current Ratio | 4.31 |
Quick Ratio | 3.20 |
Debt / Equity | 70.39 |
Debt / EBITDA | 2.72 |
Debt / FCF | -3.07 |
Interest Coverage | 2.99 |
Financial Efficiency
Return on equity (ROE) is -8.16% and return on invested capital (ROIC) is 6.02%.
Return on Equity (ROE) | -8.16% |
Return on Assets (ROA) | 4.70% |
Return on Capital (ROIC) | 6.02% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.51 |
Inventory Turnover | 2.63 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.56% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -12.56% |
50-Day Moving Average | 13,534.00 |
200-Day Moving Average | 14,472.50 |
Relative Strength Index (RSI) | 53.77 |
Average Volume (20 Days) | 20 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Median Diagnostics had revenue of KRW 7.86 billion and -567.58 million in losses. Loss per share was -496.00.
Revenue | 7.86B |
Gross Profit | 4.95B |
Operating Income | 1.17B |
Pretax Income | -1.17B |
Net Income | -567.58M |
EBITDA | 1.59B |
EBIT | 1.17B |
Loss Per Share | -496.00 |
Balance Sheet
The company has 3.66 billion in cash and 4.33 billion in debt, giving a net cash position of -672.04 million or -384.79 per share.
Cash & Cash Equivalents | 3.66B |
Total Debt | 4.33B |
Net Cash | -672.04M |
Net Cash Per Share | -384.79 |
Equity (Book Value) | 6.15B |
Book Value Per Share | 5,378.46 |
Working Capital | 5.11B |
Cash Flow
In the last 12 months, operating cash flow was -6.05 million and capital expenditures -1.41 billion, giving a free cash flow of -1.41 billion.
Operating Cash Flow | -6.05M |
Capital Expenditures | -1.41B |
Free Cash Flow | -1.41B |
FCF Per Share | -809.17 |
Margins
Gross margin is 63.01%, with operating and profit margins of 14.86% and -7.22%.
Gross Margin | 63.01% |
Operating Margin | 14.86% |
Pretax Margin | -14.93% |
Profit Margin | -7.22% |
EBITDA Margin | 20.25% |
EBIT Margin | 14.86% |
FCF Margin | -17.98% |
Dividends & Yields
Median Diagnostics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -3.55% |
FCF Yield | -5.78% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |